(XZEM) Xtrackers MSCI Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BG370F43 • Global Emerging Markets Equity
XZEM: Stocks, Bonds, Emerging Markets, Equities
Xtrackers MSCI Emerging Markets ESG UCITS ETF 1C (XETRA:XZEM) is a Germany-domiciled ETF designed to offer exposure to emerging markets with a focus on environmental, social, and governance (ESG) criteria. Listed on XETRA, it provides investors with a diversified portfolio of emerging market equities that meet specific ESG standards, filtered through the Morningstar EM TME NR USD index.
With an AUM of 1634.46M EUR, this ETF is part of the broader Xtrackers suite, known for its transparency and tracking efficiency. It is structured as a UCITS-compliant fund, which ensures adherence to European regulatory standards, offering a layer of investor protection and operational clarity. The fund tracks the Morningstar Emerging Markets Target Market Exposure Net Return USD index, which is designed to capture the performance of emerging market equities while applying ESG filters to exclude companies that do not meet certain sustainability criteria.
For investors and fund managers, this ETF is notable for its ESG focus, which aligns with the growing demand for sustainable investing. It offers a cost-effective way to gain exposure to a diversified basket of emerging market equities while adhering to ESG principles. The fund’s structure allows for liquidity and ease of trading on the XETRA exchange, making it accessible to both institutional and retail investors. Additionally, the ETF’s ESG screens may help investors mitigate certain risks associated with non-ESG compliant companies, though it’s important to evaluate how these screens are applied and their potential impact on performance.
The fund’s expense ratio and tracking difference are critical metrics for evaluating its efficiency. While the description does not specify these figures, they are essential for investors assessing the ETF’s cost-effectiveness and ability to deliver returns in line with its underlying index. As with any ETF, understanding the index methodology, including the specific ESG criteria used, is crucial for aligning the investment with individual or institutional objectives.
Additional Sources for XZEM ETF
XZEM ETF Overview
Market Cap in USD | 1,772m |
Category | Global Emerging Markets Equity |
TER | 0.25% |
IPO / Inception | 2019-10-15 |
XZEM ETF Ratings
Growth 5y | 21.3% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -9.44 |
Analysts | - |
Fair Price Momentum | 41.87 EUR |
Fair Price DCF | - |
XZEM Dividends
No Dividends PaidXZEM Growth Ratios
Growth Correlation 3m | 44.8% |
Growth Correlation 12m | 87.1% |
Growth Correlation 5y | -28.5% |
CAGR 5y | 6.56% |
CAGR/Max DD 5y | 0.18 |
Sharpe Ratio 12m | 1.57 |
Alpha | 7.35 |
Beta | 0.74 |
Volatility | 19.08% |
Current Volume | 0.6k |
Average Volume 20d | 4.3k |
As of March 14, 2025, the stock is trading at EUR 46.30 with a total of 576 shares traded.
Over the past week, the price has changed by -2.81%, over one month by -5.47%, over three months by -2.20% and over the past year by +13.04%.
Neither. Based on ValueRay Analyses, Xtrackers MSCI Emerging is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 21.25 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XZEM as of March 2025 is 41.87. This means that XZEM is currently overvalued and has a potential downside of -9.57%.
Xtrackers MSCI Emerging has no consensus analysts rating.
According to ValueRays Forecast Model, XZEM Xtrackers MSCI Emerging will be worth about 46.6 in March 2026. The stock is currently trading at 46.30. This means that the stock has a potential upside of +0.67%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 46.6 | 0.7% |